#cirrhosis

Non-alcoholic fatty liver disease can lead to cirrhosis and liver cancer.

Liver disease such as viral hepatitis and other liver conditions can cause damage to the liver which can range from mild to severe.

People with cirrhosis don’t have an increased risk of developing liver cancer when taking interferon-free treatment.

A recent study analyzed health outcomes among those with decompensated cirrhosis treated with Sovaldi-based regimens.

Damage to the liver can be caused by many factors, such as the hepatitis virus. What is the difference between fibrosis and cirrhosis?

A frank talk about hepatic encephalopathy, including causes, treatments, and symptoms.

The annual scientific meeting on liver health revealed exciting new findings concerning the battle against the hep C epidemic.

In a recent study of more than 600 HIV-positive adults, 93 percent were cured of hep C.

This is according to an analysis of nearly 5,000 Italians recently treated for the virus.

The costs rise particularly steeply for those who quickly progress to end-stage liver disease.

This is according to a recent mathematical modeling study.

A recent analysis of data from a roster of clinical trials yielded reassuring findings for this group of women who have hepatitis C.

Those for whom Mavyret did not work the first time had a high cure rate with this intensified retreatment regimen.

In a recent trial, 12 weeks of the drug combination worked well regardless of whether individuals had drug-resistant virus.

Treating hepatitis C among those with cirrhosis reduces hospitalizations.

Use of drugs like Nexium or Prilosec is tied to progression to cirrhosis, decompensated cirrhosis and liver cancer in this population.